| 2016-10-07 10:26:27|
OPHT, NVS… 10:26 10/07 10/07/16
Sector sources name Ophthotech as possible takeover target, Dealreporter says
Sector sources told Dealreporter that Ophthotech (OPHT) could draw acquisition interest in the next year, assuming that its late-stage data for its wet AMD drug, Fovista, is positive, according to contacts. Novartis (NVS), Allergan (AGN), Shire (SHPG), Bayer (BAYRY) and Sanofi (SNY) were all listed by the sources as potential bidders, the report added. Ophthotech shares are up about 3% in early trading.